LeadIQ logo
Learn more at LeadIQ.com

Insights

Expanding Therapies BioMarin Pharmaceutical Inc. is developing therapies to increase protein levels through targeting regulatory RNA sequences. This presents an opportunity for partnerships with organizations looking to advance novel therapeutics in the biotechnology sector.

Top Talent Recruitment BioMarin's recent hiring of industry executives like James Sabry brings in experienced leadership that can drive business growth. Leveraging this expertise through collaborations or services could enhance sales strategies.

Restructuring Efforts The recent headcount reductions by BioMarin may indicate a need for streamlined processes or new efficiencies. Providing solutions that support workforce optimization and cost savings could be a valuable sales angle.

Financial Stability With a significant revenue base of over $1 billion, BioMarin showcases financial stability in the biotechnology research sector. Offering products or services that align with their research and development goals can foster mutually beneficial partnerships.

Competitive Benchmarking Comparing BioMarin to similar companies like Amicus Therapeutics and Vertex Pharmaceuticals, who also have substantial revenue, can provide insights into market positioning and strategies. Identifying differentiation points can guide targeted sales approaches.

Similar companies to BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. Tech Stack

BioMarin Pharmaceutical Inc. uses 8 technology products and services including AutoCad, OneTrust, git, and more. Explore BioMarin Pharmaceutical Inc.'s tech stack below.

  • AutoCad
    Cad & Graphics
  • OneTrust
    Cookie Compliance
  • git
    Development
  • Oracle ERP
    Enterprise
  • Module Federation
    Miscellaneous
  • .NET
    Programming Languages
  • Piwik
    System Analytics & Monitoring
  • ZURB Foundation
    UI Frameworks

Media & News

BioMarin Pharmaceutical Inc.'s Email Address Formats

BioMarin Pharmaceutical Inc. uses at least 2 format(s):
BioMarin Pharmaceutical Inc. Email FormatsExamplePercentage
First.Last@bmrn.comJohn.Doe@bmrn.com
62%
FLast@bmrn.comJDoe@bmrn.com
33%
Last.First@bmrn.comDoe.John@bmrn.com
1%
LFirst@bmrn.comDJohn@bmrn.com
1%
First.Middle@bmrn.comJohn.Michael@bmrn.com
1%
First@bmrn.comJohn@bmrn.com
1%
FL@bmrn.comJD@bmrn.com
1%
First.Last@biomarin.comJohn.Doe@biomarin.com
87%
FLast@biomarin.comJDoe@biomarin.com
12%
First.Middle@biomarin.comJohn.Michael@biomarin.com
1%

Frequently Asked Questions

Where is BioMarin Pharmaceutical Inc.'s headquarters located?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc.'s main headquarters is located at 770 Lindaro Street San Rafael, CA 94901 US. The company has employees across 6 continents, including North AmericaEuropeSouth America.

What is BioMarin Pharmaceutical Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact BioMarin Pharmaceutical Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioMarin Pharmaceutical Inc.'s stock symbol?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc. is a publicly traded company; the company's stock symbol is BMRN.

What is BioMarin Pharmaceutical Inc.'s official website and social media links?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc.'s official website is biomarin.com and has social profiles on LinkedIn.

How much revenue does BioMarin Pharmaceutical Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, BioMarin Pharmaceutical Inc.'s annual revenue reached $1.5B.

What is BioMarin Pharmaceutical Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc.'s SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioMarin Pharmaceutical Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, BioMarin Pharmaceutical Inc. has approximately 3.5K employees across 6 continents, including North AmericaEuropeSouth America. Key team members include CEO: J. B.CMO Packaging Operations Manager: K. P.Chief Commercial Officer (cco): C. H.. Explore BioMarin Pharmaceutical Inc.'s employee directory with LeadIQ.

What industry does BioMarin Pharmaceutical Inc. belong to?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc. operates in the Biotechnology Research industry.

What technology does BioMarin Pharmaceutical Inc. use?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc.'s tech stack includes AutoCadOneTrustgitOracle ERPModule Federation.NETPiwikZURB Foundation.

What is BioMarin Pharmaceutical Inc.'s email format?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc.'s email format typically follows the pattern of . Find more BioMarin Pharmaceutical Inc. email formats with LeadIQ.

How much funding has BioMarin Pharmaceutical Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, BioMarin Pharmaceutical Inc. has raised $586M in funding. The last funding round occurred on May 11, 2020 for $586M.

When was BioMarin Pharmaceutical Inc. founded?

Minus sign iconPlus sign icon
BioMarin Pharmaceutical Inc. was founded in 1997.
BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact.


Recruitment Fraud Alert Notice
 
Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral.
 
In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity.
 
If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via www.ic3.gov. We would also suggest you notify your local police department and monitor your credit.

We appreciate your interest in BioMarin & encourage you to visit http://careers.biomarin.com/career-areas to review job opportunities.

Section iconCompany Overview

Headquarters
770 Lindaro Street San Rafael, CA 94901 US
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
Stock Symbol
BMRN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1997
Employees
1001-5000

Section iconFunding & Financials

  • $586M

    BioMarin Pharmaceutical Inc. has raised a total of $586M of funding over 1 rounds. Their latest funding round was raised on May 11, 2020 in the amount of $586M.

  • $1B

    BioMarin Pharmaceutical Inc.'s revenue is in the range of $1B

Section iconFunding & Financials

  • $586M

    BioMarin Pharmaceutical Inc. has raised a total of $586M of funding over 1 rounds. Their latest funding round was raised on May 11, 2020 in the amount of $586M.

  • $1B

    BioMarin Pharmaceutical Inc.'s revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.